XP press release ( XP ): Q4 Non-GAAP EPS of R$2.56. Revenue of R$4.95B (+10.2% Y/Y). Client Assets totaled R$1.5 trillion in 4Q25, up 16% YoY and 5% QoQ. Year-over-year growth was driven by R$94 billion net inflow and R$111 billion of market appreciation. In 4Q25, Net Inflow was R$32 billion, and Retail Net Inflow was R$20 billion, in line with both year-on-year and quarter-on-quarter levels. Accu...
XP press release ( XP ): Q4 Non-GAAP EPS of R$2.56. Revenue of R$4.95B (+10.2% Y/Y). Client Assets totaled R$1.5 trillion in 4Q25, up 16% YoY and 5% QoQ. Year-over-year growth was driven by R$94 billion net inflow and R$111 billion of market appreciation. In 4Q25, Net Inflow was R$32 billion, and Retail Net Inflow was R$20 billion, in line with both year-on-year and quarter-on-quarter levels. Accumulated Retail Net Inflow for the full year of 2025 was R$94 billion, or 13% lower compared to 2024. Active clients grew 2% YoY and remained stable QoQ, totaling 4.8 million in 4Q25. In 4Q25, Total TPV was R$14.6 billion, a 11% growth YoY, and 11% increase QoQ. For the full year of 2025, Total TPV was R$52.2 billion, 9% higher compared to 2024. Total Active Cards were 1.5 million in 4Q25, a growth of 10% YoY and being broadly stable QoQ, being 1.0 million Credit Cards and 0.5 million Active Debit Cards. More on XP XP Remains Attractive Despite Qualitative Concerns XP Inc. Q3: Flows Recover, Advisory Scales Up, And Risk Perception Declines XP Inc. 2025 Q3 - Results - Earnings Call Presentation XP Q4 2025 Earnings Preview XP Inc. signals accelerating retail net new money to BRL 20B per quarter while advancing fee-based model
hapabapa Twilio ( TWLO ) shares fell around 2% in extended trading on Thursday even as the communications software company reported fourth-quarter results and guidance that were above Wall Street's forecast. For the period ending Dec. 31, Twilio said it earned an adjusted $1.33 per share as sales came in at $1.37B, up 14.3% year-over-year. Organic revenue growth was 12% during the period. Analysts...
hapabapa Twilio ( TWLO ) shares fell around 2% in extended trading on Thursday even as the communications software company reported fourth-quarter results and guidance that were above Wall Street's forecast. For the period ending Dec. 31, Twilio said it earned an adjusted $1.33 per share as sales came in at $1.37B, up 14.3% year-over-year. Organic revenue growth was 12% during the period. Analysts had expected the company to earn an adjusted $1.23 per share on $1.32B in revenue. “2025 was one of the most balanced and successful years of execution in Twilio’s history and has fundamentally transformed our financial profile and innovation velocity,” said Khozema Shipchandler, CEO of Twilio, in a statement . “We accelerated revenue growth, expanded operating margins, and delivered significant growth in free cash flow. Importantly, our vision is resonating with customers and Twilio is quickly becoming a foundational infrastructure layer in the age of AI.” For the first-quarter of fiscal 2026, Twilio expects sales to be between $1.335B and $1.345B, above the $1.29B estimate. Adjusted earnings are forecast to be between $1.21 and $1.26, compared to the consensus of $1.24 per share. Looking ahead to fiscal 2026, Twilio expects revenue growth to be between 11.5% and 12.5% year-over-year, including an organic growth rate of 8% to 9%. That translated to full-year sales between $5.65B and $5.7B, above the $5.47B estimate. The company will host a conference call at 5 p.m. EST to discuss the results. More on Twilio Twilio: Too Expensive For An Upgrade, Even As Upcoming Earnings Look Promising Twilio: A Strong Agentic AI Play Twilio: 2025's Acceleration Ain't Stopping Twilio Q4 earnings on deck: What to expect Notable analyst calls this week: Palantir, Merck and Lockheed Martin among top picks
Trupanion press release ( TRUP ): Q4 GAAP EPS of $0.13 misses by $0.03 . Revenue of $376.85M (+11.7% Y/Y) beats by $0.96M . More on Trupanion Seeking Alpha’s Quant Rating on Trupanion Historical earnings data for Trupanion Financial information for Trupanion
Trupanion press release ( TRUP ): Q4 GAAP EPS of $0.13 misses by $0.03 . Revenue of $376.85M (+11.7% Y/Y) beats by $0.96M . More on Trupanion Seeking Alpha’s Quant Rating on Trupanion Historical earnings data for Trupanion Financial information for Trupanion
Ralf Hahn Hercules Capital ( HTGC ) delivered Q4 earnings that modestly beat the Wall Street consensus, ending a year that scored new records. "Our record-breaking performance in 2025 — which included achieving all-time highs in new debt and equity commitments, gross fundings, net debt portfolio growth, and investment income — reflects our differentiated approach to investing, the strength of the ...
Ralf Hahn Hercules Capital ( HTGC ) delivered Q4 earnings that modestly beat the Wall Street consensus, ending a year that scored new records. "Our record-breaking performance in 2025 — which included achieving all-time highs in new debt and equity commitments, gross fundings, net debt portfolio growth, and investment income — reflects our differentiated approach to investing, the strength of the Hercules platform and our unrivaled standing in the venture lending market," said CEO and Chief Investment Officer Scott Bluestein. Q4 net investment income per share of $0.48, just topping the average analyst estimate of $0.49, declined from $0.49 in Q3 and $0.49 in Q4 2024. Total investment income of $137.4M, missing the $141.6M consensus, fell from $138.1M in the prior quarter and increased from $121.8M in the year-ago quarter Net asset value per share of $12.13 at Dec. 31, 2025, grew from $12.05 at Sept. 30. Total net operating expenses were $50.5M, up from $49.5M in Q3 and $121.8M in the previous year’s Q4. During the quarter, Hercules Capital ( HTGC ) realized early loan repayments of $149.7M, which, along with normal scheduled amortization of $19.5M, resulted in total debt repayments of $169.2M. It originated gross new debt and equity commitments totaling $1.06B, a record and increase of 71% Y/Y, and gross new fundings totaled $522.3M. Hercules Capital ( HTGC ) stock edged up 0.8% in after-hours trading. Conference call at 5:00 PM More on Hercules Capital Hercules Capital: Why I Am Buying The Liberation Day-Like Collapse On Overblown AI Panic Hercules Capital: 7 Reasons Why This Is The Top BDC For 2026 Hercules Capital: A BDC That Ticks The Boxes For Retirement Income Hercules Capital reports Q4 results
Videos circulating on social media showed the pavement buckling and plunging into a pit stretching dozens of meters A section of a Shanghai subway construction site collapsed Thursday morning, opening a massive sinkhole that swallowed temporary structures and prompted the evacuation of nearby office buildings and residential complexes in the city’s southwest. The accident occurred at a work site f...
Videos circulating on social media showed the pavement buckling and plunging into a pit stretching dozens of meters A section of a Shanghai subway construction site collapsed Thursday morning, opening a massive sinkhole that swallowed temporary structures and prompted the evacuation of nearby office buildings and residential complexes in the city’s southwest. The accident occurred at a work site for the Jiamin Metro Line. No casualties were reported. Problems began Wednesday morning, when Shanghai Shentie Investment Co., the state-owned enterprise overseeing the project, reported water leakage at the construction site for the Qixin Road Station. Despite efforts by the contractor, China Railway Tunnel Group, to plug the leak, the ground gave way early Thursday.
Fortune Brands Innovations ( FBIN ) appointed Amit Banati as chief executive officer effective May 13, 2026. Banati will succeed Nicholas Fink, who will step down as CEO and board member on April 1, 2026. Board chair Susan Kilsby will serve as executive chair and assume CEO duties during the transition period beginning February 12, 2026, before returning to non-executive chair. Banati currently se...
Fortune Brands Innovations ( FBIN ) appointed Amit Banati as chief executive officer effective May 13, 2026. Banati will succeed Nicholas Fink, who will step down as CEO and board member on April 1, 2026. Board chair Susan Kilsby will serve as executive chair and assume CEO duties during the transition period beginning February 12, 2026, before returning to non-executive chair. Banati currently serves as CFO of Kenvue and previously held senior leadership roles at Kellanova (formerly Kellogg), Mondelez, Cadbury Schweppes, and Procter & Gamble. Banati will continue to serve as a member of the Fortune Brands Board following his appointment as CEO. FBIN shares down 11.7% post-market. More on Fortune Brands Innovations Fortune Brands Innovations Q4 2025 Earnings Preview Seeking Alpha’s Quant Rating on Fortune Brands Innovations Historical earnings data for Fortune Brands Innovations Dividend scorecard for Fortune Brands Innovations Financial information for Fortune Brands Innovations
Mohawk press release ( MHK ): Q4 Non-GAAP EPS of $2.00 beats by $0.02 . Revenue of $2.7B (+2.3% Y/Y) beats by $20M . Shares -2.38% . More on Mohawk Mohawk Industries: An Upgrade Is Perilously Close Mohawk Q4 2025 Earnings Preview Mohawk Q4 2025 Earnings Preview Seeking Alpha’s Quant Rating on Mohawk Historical earnings data for Mohawk
Mohawk press release ( MHK ): Q4 Non-GAAP EPS of $2.00 beats by $0.02 . Revenue of $2.7B (+2.3% Y/Y) beats by $20M . Shares -2.38% . More on Mohawk Mohawk Industries: An Upgrade Is Perilously Close Mohawk Q4 2025 Earnings Preview Mohawk Q4 2025 Earnings Preview Seeking Alpha’s Quant Rating on Mohawk Historical earnings data for Mohawk
Procore Technologies press release ( PCOR ): Q4 Non-GAAP EPS of $0.37 beats by $0.01 . Revenue of $349.11M (+15.6% Y/Y) beats by $8.35M . First Quarter and Full Year 2026 Outlook: Procore is providing the following guidance for the first quarter and full year 2026: First Quarter 2026 Outlook: Revenue is expected to be in the range of $351 million to $353 million, representing year-over-year growth...
Procore Technologies press release ( PCOR ): Q4 Non-GAAP EPS of $0.37 beats by $0.01 . Revenue of $349.11M (+15.6% Y/Y) beats by $8.35M . First Quarter and Full Year 2026 Outlook: Procore is providing the following guidance for the first quarter and full year 2026: First Quarter 2026 Outlook: Revenue is expected to be in the range of $351 million to $353 million, representing year-over-year growth of 13% to 14%. Non-GAAP operating margin is expected to be in the range of 14% to 15%. Full Year 2026 Outlook: Revenue is expected to be in the range of $1,489 million to $1,494 million, representing year-over-year growth of 13%. Non-GAAP operating margin is expected to be in the range of 17.5% to 18%. Free cash flow margin is expected to be 19%. Shares +8.6% AH More on Procore Technologies Procore: AI Monetization Is Coming Procore Technologies, Inc. (PCOR) Presents at Barclays 23rd Annual Global Technology Conference Transcript Procore Technologies, Inc. (PCOR) Discusses New CEO's Early Observations and Strategic Vision Transcript Procore Technologies Q4 2025 Earnings Preview Procore acquires Datagrid
Bright Horizons press release ( BFAM ): Q4 Non-GAAP EPS of $1.15 beats by $0.03 . Revenue of $734M (+8.9% Y/Y) beats by $6.56M . More on Bright Horizons Bright Horizons Q4 2025 Earnings Preview Seeking Alpha’s Quant Rating on Bright Horizons Historical earnings data for Bright Horizons Financial information for Bright Horizons
Bright Horizons press release ( BFAM ): Q4 Non-GAAP EPS of $1.15 beats by $0.03 . Revenue of $734M (+8.9% Y/Y) beats by $6.56M . More on Bright Horizons Bright Horizons Q4 2025 Earnings Preview Seeking Alpha’s Quant Rating on Bright Horizons Historical earnings data for Bright Horizons Financial information for Bright Horizons
CAE press release ( CAE ): Q3 Non-GAAP EPS of C$0.34. Revenue of C$1.25B (+2.5% Y/Y). More on CAE Inc. CAE: Trump Threats Hurt The Stock, But I Remain Bullish CAE Inc. 2026 Q2 - Results - Earnings Call Presentation CAE Q3 2026 Earnings Preview Seeking Alpha’s Quant Rating on CAE Inc. Historical earnings data for CAE Inc.
CAE press release ( CAE ): Q3 Non-GAAP EPS of C$0.34. Revenue of C$1.25B (+2.5% Y/Y). More on CAE Inc. CAE: Trump Threats Hurt The Stock, But I Remain Bullish CAE Inc. 2026 Q2 - Results - Earnings Call Presentation CAE Q3 2026 Earnings Preview Seeking Alpha’s Quant Rating on CAE Inc. Historical earnings data for CAE Inc.
Nu Skin press release ( NUS ): Q4 GAAP EPS of $0.29 misses by $0.01 . Revenue of $370.3M (-16.9% Y/Y) misses by $12.4M . Shares -10.97% . Q1 and Full-year 2026 Outlook Q1 2026 Revenue $320 to $340 million; (12)% to (7)% Approximately (1)% FX impact Q1 2026 EPS $0.10 to $0.20 2026 Revenue $1.35 to $1.50 billion; (9)% to 1% Approximately (1)% FX impact 2026 EPS $0.80 to $1.20 Click to enlarge Q1 Rev...
Nu Skin press release ( NUS ): Q4 GAAP EPS of $0.29 misses by $0.01 . Revenue of $370.3M (-16.9% Y/Y) misses by $12.4M . Shares -10.97% . Q1 and Full-year 2026 Outlook Q1 2026 Revenue $320 to $340 million; (12)% to (7)% Approximately (1)% FX impact Q1 2026 EPS $0.10 to $0.20 2026 Revenue $1.35 to $1.50 billion; (9)% to 1% Approximately (1)% FX impact 2026 EPS $0.80 to $1.20 Click to enlarge Q1 Revenue consensus of $356.80M FY Revenue consensus is $1.53B More on Nu Skin Nu Skin: Valuation Is Low, But Challenges Remain Nu Skin Q4 2025 Earnings Preview Seeking Alpha’s Quant Rating on Nu Skin Historical earnings data for Nu Skin Dividend scorecard for Nu Skin
Kinsale Capital press release ( KNSL ): Q4 Non-GAAP EPS of $5.81 beats by $0.50 . Revenue of $483.27M (+17.3% Y/Y) beats by $15.89M . More on Kinsale Capital Kinsale: A Quality Player In E&S Insurance Kinsale Capital: Writing Insurance On An Insurance Company For 23% Yield Kinsale Capital Group: A Great Business For A Fair Price Kinsale Capital Q4 2025 Earnings Preview Kinsale Capital Group author...
Kinsale Capital press release ( KNSL ): Q4 Non-GAAP EPS of $5.81 beats by $0.50 . Revenue of $483.27M (+17.3% Y/Y) beats by $15.89M . More on Kinsale Capital Kinsale: A Quality Player In E&S Insurance Kinsale Capital: Writing Insurance On An Insurance Company For 23% Yield Kinsale Capital Group: A Great Business For A Fair Price Kinsale Capital Q4 2025 Earnings Preview Kinsale Capital Group authorizes $250M share repurchase program More on Kinsale Capital Kinsale: A Quality Player In E&S Insurance Kinsale Capital: Writing Insurance On An Insurance Company For 23% Yield Kinsale Capital Group: A Great Business For A Fair Price Kinsale Capital Q4 2025 Earnings Preview Kinsale Capital Group authorizes $250M share repurchase program
NervGen Pharma ( NGEN:CA ) announced that chief financial officer Bill Adams will retire effective March 15, 2026. Adams will remain in an advisory role after his retirement to support a smooth leadership transition. More on NervGen Pharma NervGen Pharma announces $10M non-brokered private placement Seeking Alpha’s Quant Rating on NervGen Pharma Historical earnings data for NervGen Pharma Financia...
NervGen Pharma ( NGEN:CA ) announced that chief financial officer Bill Adams will retire effective March 15, 2026. Adams will remain in an advisory role after his retirement to support a smooth leadership transition. More on NervGen Pharma NervGen Pharma announces $10M non-brokered private placement Seeking Alpha’s Quant Rating on NervGen Pharma Historical earnings data for NervGen Pharma Financial information for NervGen Pharma
We Have Now Reached "Gunperson"-Level Absurdity Authored by Jenna McCarthy via 'Jenna's Side Rocks' substack, By now you’ve surely heard about Tuesday’s horrific school shooting in Tumbler Ridge —a tiny, remote Canadian town where the biggest excitement is probably a moose spotting on Nextdoor—that left nine people dead and more than two dozen injured. Monstrous would be an insult to monsters ever...
We Have Now Reached "Gunperson"-Level Absurdity Authored by Jenna McCarthy via 'Jenna's Side Rocks' substack, By now you’ve surely heard about Tuesday’s horrific school shooting in Tumbler Ridge —a tiny, remote Canadian town where the biggest excitement is probably a moose spotting on Nextdoor—that left nine people dead and more than two dozen injured. Monstrous would be an insult to monsters everywhere. It’s the deadliest mass shooting Canada has seen in more than thirty years. The details are unimaginable, the community is destroyed, survivors are traumatized for life, and none of it is even remotely funny. The news coverage, however, could easily be nominated for a Primetime Emmy in the Outstanding Comedy Writing category. Within minutes of the rampage, alerts went out describing the suspect as a “ female in a dress .” The minute I saw that, I knew. I mean, have you ever—even once—seen an alleged perpetrator described as a “male in pants” or a “female wearing shoes?” Of course not! It’s “armed female” or “adult male” or, if the subject is still on the loose, maybe “a white male in a neon green hoodie and purple parachute pants.” But never-not-ever is it “a human in human clothing.” They only threw the dress part in there to avoid stating a politically inconvenient fact, upsetting advertisers, or toppling their own carefully constructed narrative. By the time officials reached the podium to deliver a press briefing, the description had morphed into “ a gunperson .” A gunperson . As if the word “shooter” was insufficiently inclusive or somehow accidentally implied gender? The press spent more time agonizing over culturally sanitized euphemisms than reporting the actual details of the crime. By early afternoon, every major outlet was doing verbal Pilates to avoid saying the one thing the adults in the room had already figured out: the “female in a dress” was a biological male transvestite . Reporters tiptoed around the truth like it was a sleeping dragon. A lot of “...
Coherus Oncology ( CHRS ) on Thursday announced a proposed underwritten public offering of its common stock. In addition, Coherus intends to grant the underwriters a 30-day option to purchase additional shares of its common stock in an amount up to 15% of the shares offered in the offering, at the public offering price per share less underwriting discounts and commissions. All of the shares in the...
Coherus Oncology ( CHRS ) on Thursday announced a proposed underwritten public offering of its common stock. In addition, Coherus intends to grant the underwriters a 30-day option to purchase additional shares of its common stock in an amount up to 15% of the shares offered in the offering, at the public offering price per share less underwriting discounts and commissions. All of the shares in the offering are being offered by Coherus. Coherus intends to use the net proceeds from the proposed offering to support the ongoing commercialization of LOQTORZI (toripalimab-tpzi), to continue clinical development of its product candidates, and for working capital and other general corporate purposes. CHRS -9.45% after hours to $1.82. Source: Press Release More on Coherus BioSciences Coherus Oncology, Inc. (CHRS) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript Coherus Oncology: A Two-Pronged March With Mid-2026 Implications Coherus, J&J agree to evaluate combination prostate cancer treatment Coherus Oncology a new outperform at Oppenheimer on tagmokitug potential Seeking Alpha’s Quant Rating on Coherus BioSciences
10x Genomics press release ( TXG ): Q4 GAAP EPS of -$0.13 beats by $0.08 . Revenue of $166M (+0.6% Y/Y) beats by $5.65M . 10x Genomics expects full year 2026 revenue to be in the range of $600 million to $625 million vs $611.77M consensus. Excluding the non-recurring license and royalty revenue related to patent litigation settlements in 2025, this represents 0% to 4% growth over full year 2025. S...
10x Genomics press release ( TXG ): Q4 GAAP EPS of -$0.13 beats by $0.08 . Revenue of $166M (+0.6% Y/Y) beats by $5.65M . 10x Genomics expects full year 2026 revenue to be in the range of $600 million to $625 million vs $611.77M consensus. Excluding the non-recurring license and royalty revenue related to patent litigation settlements in 2025, this represents 0% to 4% growth over full year 2025. Shares -3% . More on 10x Genomics 10x Genomics, Inc. (TXG) Presents at 44th Annual J.P. Morgan Healthcare Conference - Slideshow 10x Genomics, Inc. (TXG) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript 10x Genomics' Products Are Well-Received, But US Spending Weakness Stifles Growth 10x Genomics Q4 2025 Earnings Preview 10x Genomics sees uptick in Q4 revenue despite softer FY sales
Eversource Energy press release ( ES ): Q4 Non-GAAP EPS of $1.12 beats by $0.02 . Eversource reported fourth quarter 2025 earnings of $421.3 million, or $1.12 per share, compared with fourth quarter 2024 earnings of $72.5 million, or $0.20 per share. Non-GAAP earnings totaled $421.3 million, or $1.12 per share, in the fourth quarter of 2025 and $370.8 million 1 , or $1.01 per share 1 , in the four...
Eversource Energy press release ( ES ): Q4 Non-GAAP EPS of $1.12 beats by $0.02 . Eversource reported fourth quarter 2025 earnings of $421.3 million, or $1.12 per share, compared with fourth quarter 2024 earnings of $72.5 million, or $0.20 per share. Non-GAAP earnings totaled $421.3 million, or $1.12 per share, in the fourth quarter of 2025 and $370.8 million 1 , or $1.01 per share 1 , in the fourth quarter of 2024. More on Eversource Energy Eversource Energy: Risks Abound, But Rewards Are Outsized Eversource Energy: The Self-Help Story Is Playing Out Eversource Energy Q4 2025 Earnings Preview U.S. offshore wind halt seen as short-lived, Goldman Sachs says Seeking Alpha’s Quant Rating on Eversource Energy
Healthcare Realty press release ( HR ): Q4 FFO of $0.40 in-line. Revenue of $286.3M (-7.6% Y/Y) beats by $1.93M . The Company's 2026 per share estimated guidance ranges are as follows: ACTUAL 2026 GUIDANCE 2025 LOW HIGH Earnings per share $ (0.71 ) $ (0.05 ) $ 0.05 NAREIT FFO per share $ 1.38 $ 1.44 $ 1.50 Normalized FFO per share $ 1.61 $ 1.58 $ 1.64 Same Store Cash NOI growth 4.8 % 3.5 % 4.5 % C...
Healthcare Realty press release ( HR ): Q4 FFO of $0.40 in-line. Revenue of $286.3M (-7.6% Y/Y) beats by $1.93M . The Company's 2026 per share estimated guidance ranges are as follows: ACTUAL 2026 GUIDANCE 2025 LOW HIGH Earnings per share $ (0.71 ) $ (0.05 ) $ 0.05 NAREIT FFO per share $ 1.38 $ 1.44 $ 1.50 Normalized FFO per share $ 1.61 $ 1.58 $ 1.64 Same Store Cash NOI growth 4.8 % 3.5 % 4.5 % Click to enlarge More on Healthcare Realty Healthcare Realty: Buy This Durable REIT While It's Undervalued Mid-cap stocks with lowest dividend growth grade Healthcare Realty appoints new CFO Seeking Alpha’s Quant Rating on Healthcare Realty Historical earnings data for Healthcare Realty
CareTrust REIT press release ( CTRE ): Q4 FFO of $0.47 in-line. Revenue of $134.86M (+55.1% Y/Y) beats by $4.41M . 2026 Guidance The Company provided guidance for 2026, projecting net income attributable to CareTrust of approximately $1.45 to $1.50 per share, Normalized FFO of approximately $1.90 to $1.95 per share, and Normalized FAD of approximately $1.90 to $1.95 per share. Mr. Bunker commented...
CareTrust REIT press release ( CTRE ): Q4 FFO of $0.47 in-line. Revenue of $134.86M (+55.1% Y/Y) beats by $4.41M . 2026 Guidance The Company provided guidance for 2026, projecting net income attributable to CareTrust of approximately $1.45 to $1.50 per share, Normalized FFO of approximately $1.90 to $1.95 per share, and Normalized FAD of approximately $1.90 to $1.95 per share. Mr. Bunker commented, “The midpoints of our Normalized FFO and Normalized FAD guidance represent increases of 9.4% and 9.4%, respectively, over 2025 results. Solid market fundamentals across all asset classes within our portfolio position us well for continued growth and value creation. Our strong start to the year having deployed $214.8 million with a $500 million pipeline demonstrates our capacity to capitalize on those opportunities and continue to deliver compelling shareholder returns.” FY FFO consensus is $2.03 FY Revenue consensus is $543.35M More on CareTrust REIT CareTrust REIT: A Seniorcare Portfolio Worth Holding, While Macro Forecasts Favor It CareTrust: The REIT That's Outperforming The S&P 500 Mid-cap stocks with highest dividend growth grade CareTrust names new CFO, among other executive appointments Seeking Alpha’s Quant Rating on CareTrust REIT
Flowers Foods press release ( FLO ): Q4 Non-GAAP EPS of $0.22 beats by $0.07 . Revenue of $1.23B (+10.8% Y/Y) in-line. Net sales increased 11.0% to $1.233 billion as the extra week, Simple Mills acquisition benefit, and higher price/mix more than offset volume declines. For the 52-week Fiscal 2026, the Company Expects: Net sales of approximately $5.163 billion to $5.267 billion vs $5.20B consensus...
Flowers Foods press release ( FLO ): Q4 Non-GAAP EPS of $0.22 beats by $0.07 . Revenue of $1.23B (+10.8% Y/Y) in-line. Net sales increased 11.0% to $1.233 billion as the extra week, Simple Mills acquisition benefit, and higher price/mix more than offset volume declines. For the 52-week Fiscal 2026, the Company Expects: Net sales of approximately $5.163 billion to $5.267 billion vs $5.20B consensus, representing a -1.8% to 0.2% change compared to the prior year. Adjusted EBITDA in the range of approximately $465 million to $495 million. Adjusted diluted EPS of approximately $0.80 to $0.90 vs $0.97 consensus More on Flowers Foods Flowers Foods: The Business And The Chart Are Turning Up (Technical Analysis) Flowers Foods: The Selloff Has Gone Too Far, I'm Buying Flowers Foods: Dividend Cut More Likely After Q3'25 Results Flowers Foods Q4 2025 Earnings Preview Seeking Alpha’s Quant Rating on Flowers Foods
Erik Isakson/DigitalVision via Getty Images Arista Networks' ( ANET ) shares had increased 6% during early post-market trading on Thursday after reporting its fourth quarter 2025 financial results that demonstrated a 29% year-over-year revenue gain. For the quarter ended December 31, the cloud networking solutions company reported adjusted earnings per share of $0.82 versus the consensus estimate ...
Erik Isakson/DigitalVision via Getty Images Arista Networks' ( ANET ) shares had increased 6% during early post-market trading on Thursday after reporting its fourth quarter 2025 financial results that demonstrated a 29% year-over-year revenue gain. For the quarter ended December 31, the cloud networking solutions company reported adjusted earnings per share of $0.82 versus the consensus estimate of $0.76. GAAP EPS was $0.75 compared to the $0.69 estimate. Revenue for the quarter totaled $2.48B, which was more than the $2.39B estimate. For the entirety of 2025, Arista Networks' revenue increased 28.6% year over year to total $9B. Its GAAP gross margin remained static year over year at 64.1%. "2025 was the year of validation of our Arista 2.0 momentum, as we hit the milestone of shipping a cumulative of 150 million ports," said Arista Networks CEO Jayshree Ullal. "We exceeded both our AI networking and campus expansion goals, delivering profitable growth and revenue of $9 billion." For the quarter in progress, Arista expects revenue of $2.6B, which is more than the $2.46B estimate. It expects a non-GAAP gross margin ranging from 62% to 63%. Its non-GAAP gross margin averaged 64.6% during 2025. More on Arista Networks Arista Networks: A Wonderful Company At A Not-So-Fair Price Arista Networks: The AI Networking Growth Engine Arista Networks: AI Is Not Enough Anymore, Execution Matters Arista Networks Q4 Preview: Analysts bullish ahead of results as earnings seen rising 17% Earnings week ahead: F, KO, CSCO, SHOP, MCD, BP, AMAT, COIN, MRNA, ROKU, and more